1Y Close · As of Aug 26, 2026
KOLON LIFE SCIENCE operates in the Pharmaceuticals sector.
Legal name: KOLON LIFE SCIENCE Inc.
In fiscal year 2025, KOLON LIFE SCIENCE (102940) reported revenue of 209.0 billion KRW, up 29.5% from 161.4 billion KRW a year earlier.
Operating profit was 17.6 billion KRW and net income was 25.0 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 202.8 billion KRW, with a P/B of 0.35.
These figures can be verified in the DART filing (receipt no. 20260318001698).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 209.0B | 17.6B | 25.0B |
| 2024 | 161.4B | -22.1B | -93.1B |
| 2023 | 124.6B | -24.1B | -30.7B |
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-13 | Payment and Dispute Resolution |